homephotos Newsmarket NewsCNBC TV18's top stocks to watch out for on September 12

CNBC-TV18's top stocks to watch out for on September 12

SUMMARY

Indian shares are likely to extend Wednesday’s gains today as sentiment remained positive on hopes of fresh initiatives from the government to revive the automobile sector, which is facing its worst crisis in a decade. Additionally, positive cues from Asia on the back of the diminishing US-China trade tensions and rate cut hopes by major central banks, are likely to support the domestic market. At 06:52 AM, the SGX Nifty Futures traded higher by 0.45 percent, or 49.50 points, at 11,086.50, indicating a positive start for the Sensex and the Nifty. Here are the top stocks to watch out for:

Profile image

By CNBC-TV18 Sept 12, 2019 7:26:36 AM IST (Updated)

Listen to the Article(6 Minutes)
CNBCTV18
Image count1 / 7

Titan: ICRA has assigned "A1+" rating on the company's commercial paper worth Rs 900 crore.

State Bank of India (SBI)
Image count2 / 7

SBI: The board has approved divestment of at least 3.5 percent stake in SBI Life through an offer for sale (OFS) route. (Image: Reuters)

Srei Infrastructure finance
Image count3 / 7

Srei Infra: Brickwork Ratings downgraded the ratings for the Non-Convertible Debentures, Perpetual Debt Instrument and Commercial Paper programme aggregating to Rs 5,327.07 crore.

TorrentPharma
Image count4 / 7

Torrent Pharma: The company has received the credit rating of 'IND AA/Stable' by India Ratings and Research Private Limited for the proposed issue of Non-Convertible Debentures of Rs 300 crore.

Deal
Image count5 / 7

Walchandnagar Industries: The company and Indian Space Research Organisation's Vikram Sarabhai Space Centre (VSSC) have entered into a contract whereby WIL will manufacture and supply 'Head, Middle and Nozzle End Segments'. The contract value is Rs 77.20 crore plus. | Unsplash

L&T Finance
Image count6 / 7

L&T Finance: The board of directors has approved the offer and issuance of up to 1,00,00,000 cumulative compulsorily redeemable non-convertible preference shares (CRPS) of the face value of Rs 100 on a private placement basis.

CNBCTV18
Image count7 / 7

Dr Reddy's: The company announced the launch of Fosaprepitant for injection in the US market, approved by the USFDA.

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
arrow down

Most Read

Share Market Live

View All
Top GainersTop Losers
CurrencyCommodities
CurrencyPriceChange%Change